Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Probe Ordered Into India Patent For Roche’s Valcyte (India)

This article was originally published in PharmAsia News

Executive Summary

India's controller general ordered an investigation of a decision by the patent office in Chennai to grant F. Hoffman-LaRoche a patent for its Valcyte (valganciclovir hydrochloride) for HIV/AIDS infection developed during organ transplants. The patent office granted the patent to the Swiss drug maker without hearing opposition by a patient group, as required by law. A Mumbai lawyers group filed a pre-grant opposition last year, but the Chennai office granted the patent to Roche in September without a hearing on the group's filing. The group challenged the patent on grounds Roche relied on a pre-1995 molecule, and thus could not have received a patent under Indian law that says only post-2005 drugs are eligible for patent protection. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts